Overview

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Dose-response trial with a cocktail of recombinant major allergens of Timothy Grass Pollen (Phleum pratense)
Phase:
Phase 2
Details
Lead Sponsor:
Allergopharma GmbH & Co. KG
Treatments:
Histamine
Histamine phosphate
Immunologic Factors